Search results
Moderna's billionaire CEO reaped nearly $400 million last year. He also got a raise.
Washington Post via Yahoo News· 1 year agoStéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that...
Moderna downgraded, Gap upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 4 months agoModerna downgraded, Gap upgraded: Wall Street's top analyst calls The most talked about and market...
Moderna's betting big on personalized vaccines to treat cancer. Its CEO lays out his vision for how...
Business Insider via Yahoo News· 2 years agoModerna CEO Stéphane Bancel wants the COVID-19 vaccine developer to bring its mRNA technology to...
1 Growth Stock Down 79% That's a Screaming Buy Right Now, According to Several Wall Street Analysts
Motley Fool via Yahoo Finance· 5 months agoGrowth stocks are supposed to, well, grow. That's especially the expectation when the overall stock...
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
Motley Fool· 9 months agoOnce a relatively unknown biotech company, Moderna (NASDAQ: MRNA) became a household name when it...
The Covid Gambit: Pfizer, Moderna Struggle To Get The Jump On Covid
Investor's Business Daily· 2 years agoPfizer, BioNTech and Moderna are working feverishly to launch new Covid boosters ahead of a fall...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 1 week agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Better Bull Market Buy: Pfizer vs. Moderna
Motley Fool via Yahoo Finance· 5 months agoCOVID-19 has been especially rough for Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) investors over the last couple of years. Shares of both drugmakers...
Moderna Stock Skids Below Key Line On Unexpected Flu Shot Debacle
Investor's Business Daily· 1 year agoModerna stock skidded Tuesday on a mixed update for its messenger RNA-based flu vaccine. At the...
Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market
Investor's Business Daily· 1 year agoModerna stock rose Wednesday after the biotech said its experimental RSV vaccine proved nearly 84%...